These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 17195902

  • 1. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM, Hyman N, Mawe GM.
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [Abstract] [Full Text] [Related]

  • 2. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
    Gershon MD, Tack J.
    Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
    [Abstract] [Full Text] [Related]

  • 3. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD.
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [Abstract] [Full Text] [Related]

  • 4. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
    Crowell MD, Shetzline MA, Moses PL, Mawe GM, Talley NJ.
    Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
    [Abstract] [Full Text] [Related]

  • 5. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C, Vanden Berghe P, Tack J.
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [Abstract] [Full Text] [Related]

  • 6. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A, Boznańska P.
    Wiad Lek; 2007 Dec; 60(7-8):371-6. PubMed ID: 18175558
    [Abstract] [Full Text] [Related]

  • 7. Serotonin and GI clinical disorders.
    Spiller R.
    Neuropharmacology; 2008 Nov; 55(6):1072-80. PubMed ID: 18687345
    [Abstract] [Full Text] [Related]

  • 8. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
    Spiller R.
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
    [Abstract] [Full Text] [Related]

  • 9. Serotonergic receptors in therapeutic approaches to gastrointestinal disorders.
    Neal KB, Bornstein JC.
    Curr Opin Pharmacol; 2006 Dec; 6(6):547-52. PubMed ID: 16973419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E, Rondanelli M, Balestra B, Dellabianca A, Agazzi A, Giacosa A, Tonini M.
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [Abstract] [Full Text] [Related]

  • 12. Comparison between partial agonist (ME3412) and antagonist (alosetron) of 5-hydroxytryptamine 3 receptor on gastrointestinal function.
    Kawano K, Mori T, Fu L, Ito T, Niisato T, Yoshida S, Shiokawa S, Sato Y, Murakami H, Shishikura T.
    Neurogastroenterol Motil; 2005 Apr; 17(2):290-301. PubMed ID: 15787949
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
    Manabe N, Wong BS, Camilleri M.
    Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
    [Abstract] [Full Text] [Related]

  • 15. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation.
    Cash BD, Chey WD.
    Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1047-60. PubMed ID: 16305718
    [Abstract] [Full Text] [Related]

  • 16. Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system.
    Molderings GJ.
    Arzneimittelforschung; 2012 Apr; 62(4):157-66. PubMed ID: 22438071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
    Crowell MD.
    Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
    [Abstract] [Full Text] [Related]

  • 19. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.
    Mawe GM, Hoffman JM.
    Nat Rev Gastroenterol Hepatol; 2013 Aug; 10(8):473-86. PubMed ID: 23797870
    [Abstract] [Full Text] [Related]

  • 20. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
    Blandizzi C.
    Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.